Prognostic value of DNA methylation in head and neck cancer: a systematic review and meta-analysis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: The clinical relevance of DNA methylation in head and neck cancer (HNC) is increasingly recognized, yet controversies persist regarding its prognostic significance. We conducted a systematic review and meta-analysis adhering to the PRISMA 2020 guidelines to synthesize evidence on this association. Methods: A comprehensive literature search was performed across five databases (PubMed, Web of Science Core Collection, Cochrane Library, Embase, and Scopus) from inception to October 31, 2025. Eligible studies included original clinical investigations (prospective/retrospective cohort, case-control) reporting prognostic outcomes [overall survival (OS), disease-free survival (DFS)] stratified by DNA methylation status in histologically confirmed HNC patients. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using random-effects models. Results: Nineteen studies involving 3,251 patients were included. High DNA methylation was significantly associated with poor prognosis in HNC: OS (HR =1.50, 95% CI: 1.19–1.90, P=0.001) and DFS (HR =2.44, 95% CI: 1.74–3.47, P
Fields of Study & Subjects
Epigenetics and DNA Methylation
Head and Neck Cancer Studies
Cancer-related molecular mechanisms research
Publication details
- Journal / source
- Translational Cancer Research
- Volume
- 15
- Issue
- 3
- Pages
- 184–184
- Publication date
- 1 March 2026
- Language
- EN